Introduction {#s0001}
============

Circular RNAs (circRNAs) are covalently closed natural RNA circles resulting from a back-splicing event. Most often, they are derived from annotated host gene exons, which may give rise to alternative circRNAs depending on the exact exons involved in the back-splicing, and it has now become apparent that circRNAs comprise a large class of animal RNAs with complex developmental and tissue-specific expression patterns \[[@cit0001]\],\[[@cit0002]\]. Recently, we and others have shown a gene-regulatory function for some of the most abundantly expressed circRNAs in human tissues \[[@cit0001]\],\[[@cit0003]\]. In particular, a circular RNA located on the X chromosome contains more than 70 conserved binding sites for miRNA-7 and can act as a sponge. Accordingly, we named it circular RNA sponge for miR-7 (ciRS-7) \[[@cit0003]\]. However, the function of most circRNAs and what regulates their expression during cellular differentiation remain largely unknown. At the genetic level it has been shown that reverse complementary *Alu* repeats flanking the circularized exons can facilitate their biogenesis \[[@cit0007]\], and back-splicing can also be regulated by general splicing factors through binding to *cis*-acting splicing regulatory elements, but with regulatory rules distinct from canonical splicing \[[@cit0012]\],\[[@cit0013]\]. In addition, the transacting RNA binding factors ADAR, Quaking, FUS, HNRNPL and DHX9 have been shown to affect the biogenesis of some but not all circRNAs \[[@cit0009]\],\[[@cit0014]\]. In particular, DHX9 was recently shown to bind and resolve double stranded RNA formations caused by nearby homologues inverted *Alu* repeats leading to specific suppression of circRNAs with *Alu* mediated biogenesis \[[@cit0015]\] suggesting that DHX9 counteracts the back-splicing events that the *Alu* invasion of the human genome initiated \[[@cit0015]\].

CircRNAs have mostly been studied in brain tissues and are dynamically expressed in a spatio-temporal manner during mammalian brain development \[[@cit0002]\],\[[@cit0007]\],\[[@cit0018]\]. They are likely to be involved in neurodegenerative disorders \[[@cit0019]\],\[[@cit0020]\] and are deeply involved in human cancer \[[@cit0021]\], for instance by modulating tumor growth by affecting the Wnt/β-catenin pathway \[[@cit0022]\],\[[@cit0023]\], and some are promising as diagnostic and prognostic biomarkers \[[@cit0024]\],\[[@cit0025]\].

On the contrary, no data on circRNA expression in human epidermal stem cell (EpSC) homeostasis and differentiation are available. Therefore, we explored the expression of endogenous circRNAs during epidermal stem cell differentiation using previously published high-throughput RNA sequencing (RNA-seq) data \[[@cit0026]\]. Importantly, the sequencing libraries were prepared from total RNA after ribosomal RNA removal \[[@cit0026]\] as circRNAs lack polyA tails. Characterization of circRNAs was performed using two independent well-established bioinformatics pipelines \[[@cit0007]\],\[[@cit0011]\], and circRNAs supported by at least 10 reads per replicate in EpSCs or in the differentiated keratinocytes were further characterized bioinformatically. Finally, we analyzed RNA-seq data from individual knockdowns of *DNMT3A* and *DNMT3B*, respectively, in the EpSCs to investigate if DNA methylation may play a role in regulating circRNA expression.

Results {#s0002}
=======

Circular RNAs are abundantly expressed in EpSCs and differentiated keratinocytes {#s0002-0001}
--------------------------------------------------------------------------------

Total ribosomal depleted RNA from EpSCs and differentiated keratinocytes was deep sequenced in triplicates and analyzed using a stringent version of the find_circ pipeline \[[@cit0007]\] and the CIRCexplorer pipeline \[[@cit0011]\]. The find_circ pipeline detected 13.851 unique circRNA candidates supported by at least two head-to-tail junction-spanning reads in a single replicate within the entire dataset. The two circRNA candidates supported by most reads were clearly artifacts due to sequence homology between exon 8 of *KRT6A* and exon 8 of *KRT6C* and between exon 2 of *KRT5* and exon 2 of *KRT6A*, respectively (Figure S1A and S1B). These were not detected by CIRCexplorer and excluded from further analyses. Likewise, many of the circRNAs supported by very few reads are potentially reverse transcriptase- or sequencing artifacts. Therefore, we decided to analyze, in detail, only circRNA candidates supported by at least ten head-to-tail junction-spanning reads on average per replicate as detected by the find_circ pipeline. Among these, we manually inspected all circRNA candidates not detected by CIRCexplorer, to exclude obvious artifacts due to sequence homology, and ended up with 402 and 563 circRNA species in the EpSCs and differentiated keratinocytes, respectively ([Fig. 1A](#f0001){ref-type="fig"} and [B](#f0001){ref-type="fig"}). The reproducibility between replicates was good both when considering reads per million (RPM) across the back-splicing junction and circular-to-linear (CTL) ratios (R^2^\>0.66 for all analyses, Figure S2A and S2B) and 365 (90.8%) and 510 (90.6%) of the circRNAs were also detected by CIRCexplorer in the EpSCs and differentiated keratinocytes, respectively. Among the top 100 most highly expressed circRNAs in the EpSCs and differentiated keratinocytes, respectively, we only detected a total of three, which are not present in circBase \[[@cit0027]\], namely circRNAs produced from *C1orf116, TNS4* (*CTEN*) and *KRT5* (Figure S3A and S3B). Interestingly, the circRNA from the *KRT5* gene is derived from cryptic splice sites found within the first exon. Therefore, it was only detected by the find_circ pipeline (Figure S3A) which, in contrast to CIRCexplorer, also detects circRNAs derived from nonannotated splice sites \[[@cit0028]\]. The overlap between the circRNAs detected in the EpSCs and the differentiated keratinocytes was substantial and many circRNAs were unique, mainly to the differentiated cells ([Fig 1C](#f0001){ref-type="fig"}). The 402 and 563 circRNAs were generated from 334 and 452 host genes, respectively, and of these 24 and 42, respectively, were expressed at higher levels than their linear host genes ([Fig. 1A](#f0001){ref-type="fig"} and [B](#f0001){ref-type="fig"}). In total, 64 and 101, respectively, of the circRNAs were generated from a single exon and circRNAs composed of two exons were most frequently observed in both cell types ([Fig. 1A](#f0001){ref-type="fig"} and [B](#f0001){ref-type="fig"}). We successfully validated the RNA-seq data for selected circRNAs by amplification of cDNA with divergent primers followed by Sanger sequencing across the back-splicing junction ([Fig. 1D](#f0001){ref-type="fig"}). However, we were unable to validate the presence of circRNA from exon 1 of *KRT5*, potentially due to its small size (138 bp) and sequence homology with other loci making it difficult to design specific PCR primers. Figure 1.circRNAs are highly abundant in EpSCs and differentiated keratinocytes. (A) In the EpSCs 402 circRNA species were supported by an average of 10 reads per replicate. The circRNA derived from exon 3 of *HIPK3* was the most abundant. Selected host genes with upregulated (green) or downregulated (red) circRNAs upon differentiation are indicated. (B) In the differentiated keratinocytes 563 circRNA species were supported by an average of 10 reads per replicate. The circRNA derived from exon 3 of *HIPK3* was the most abundant. Selected host genes with upregulated (green) or downregulated (red) circRNAs upon differentiation are indicated. (C) Venn diagram illustrating the overlap of circRNAs detected in the EpSCs and the differentiated keratinocytes. (D) Validation of RNA-seq data by Sanger sequencing across back-splicing junctions of selected circRNAs.

Many circRNAs are upregulated upon differentiation of EpSCs to keratinocytes {#s0002-0002}
----------------------------------------------------------------------------

In total, 624 unique circRNAs were detected in the EpSCs and differentiated keratinocytes combined ([Fig. 1C](#f0001){ref-type="fig"}). The expression of many of these circRNAs were changed during EpSC differentiation ([Fig. 2A-C](#f0002){ref-type="fig"}). The most up- and downregulated circRNAs are listed in [Table 1](#t0001){ref-type="table"} and [Table 2](#t0002){ref-type="table"}, respectively. Overall, circRNAs were higher expressed in the differentiated cells, both when considering RPM and CTL ratios (*P*\<0.0001 for both analyses). Thirteen circRNAs were not detected in the EpSCs ([Table 1](#t0001){ref-type="table"}) while being expressed in the differentiated keratinocytes and could, therefore, not be represented in [Fig. 2A-C](#f0002){ref-type="fig"}. Likewise, circ-RNAs with host gene expression below the detection limit ([Table 1](#t0001){ref-type="table"}) are not displayed in [Fig. 2B](#f0002){ref-type="fig"} and [C](#f0002){ref-type="fig"}. Interestingly, when considering CTL ratios ([Fig. 2B](#f0002){ref-type="fig"}), some of the most upregulated circRNAs are derived from epidermal developmental genes, including *RAB6A* \[[@cit0029]\], *DSC3* \[[@cit0030]\] and *IQGAP1* \[[@cit0031]\] and two of the most upregulated circRNAs are derived from *HECTD1*, which has recently been shown to regulate the protein levels of *IQGAP1* through ubiquitination\[32\]. circRNAs derived from the *MAP3K4, CTEN*, and *ESRP1* genes, which are involved in stemness, epidermal growth factor signaling and epithelial to mesenchymal transition \[[@cit0033]\], were also upregulated during differentiation. This also applied to circRNAs from the two interacting genes *SHOC2* and *HUWE1*. SHOC2 is a scaffold protein that acts as a positive modulator of ERK1/2 signaling and it is directly regulated by its binding partner, the E3 ubiquitin ligase, HUWE1 \[[@cit0037]\]. One of the most upregulated circRNAs was derived from the *SAFB2* gene, which is likely to be involved in transcription initiation and alternative mRNA splicing \[[@cit0033]\],\[[@cit0038]\], and its homolog *SAFB1* has been shown to facilitate alternative splicing of neurogenesis genes \[[@cit0039]\] ([Fig. 2B](#f0002){ref-type="fig"}). Finally, the developmental gene *DLG1* produced four different circRNAs, which were all upregulated more than three fold (RPM) in the differentiated keratinocytes ([Table 1](#t0001){ref-type="table"}). *DLG1* has previously been shown to produce several alternatively spliced variants during keratinocyte differentiation \[[@cit0040]\]. Figure 2.Many circRNAs are upregulated during EpSCs differentiation. (A) Volcano plot of fold changes in RPM upon differentiation. (B) Volcano plot of fold changes in CTL ratios upon differentiation. (C) Many upregulated circRNAs were upregulated independent of their respective host genes and a positive correlation between fold change in RPM and fold change in CTL ratios was observed upon differentiation. Upregulated circRNAs (RPM and CTL fold change \>3) are indicated in green and stably expressed circRNAs (RPM and CTL fold change \<1.5 and \>0.67) are indicated in red. Table 1.Upregulated circRNAs during differentiation of EpSCs.Location (HG19)Host geneFold change (CTL)*P*-valueFold change (RPM)*P*-valueΔ junction spanning readsUpregulated circRNAs (Fold change in RPM\>3)     chr18:28586872-28598766*DSC3*7.4810.0233.5190.07522 chr19:5604593-5604947*SAFB2*5.9360.0003.3120.03835 chr14:31596990-31641328*HECTD1*5.9270.00312.1310.023166 chr4:48371865-48385801*SLAIN2*4.9770.0874.2340.01028 chr10:69785302-69804320*HERC4*4.9440.0045.1650.03550 chr5:142779220-142780417*NR3C1*4.9050.0063.4730.06322 chr5:78734832-78752841*HOMER1*4.8230.0203.1740.03788 chr12:116668237-116675510*MED13L*4.4970.0053.8100.04939 chr9:110062421-110074018*RAD23B*4.3980.0368.6440.01232 chr1:19244855-19246267*IFFO2*4.0250.0023.0560.03734 chr6:161455290-161471011*MAP3K4*3.6500.0003.5290.00538 chr3:196817782-196846401*DLG1*3.5260.0107.6310.04163 chr21:17205666-17214859*USP25*3.4200.0303.3330.09027 chr4:87622393-87622954*PTPN13*3.4070.0275.2470.00836 chr10:112723882-112745523*SHOC2*3.3970.0043.3440.02850 chr6:160467529-160469575*IGF2R*3.3060.0794.3360.09632 chr19:23541231-23545527*ZNF91*3.1200.0156.2120.012231 chr7:99090662-99092254*ZNF394*3.1200.0013.2780.03637 chr2:148653869-148657467*ACVR2A*3.0060.0094.0520.07245 chr4:87614739-87622954*PTPN13*2.9560.0983.6960.01443 chr16:85667519-85667738*GSE1*2.5140.0383.1280.00843 chr2:9419445-9437574*ASAP2*2.3500.0294.2800.02424 chr7:65705311-65751696*TPST1*2.1390.1553.4580.01726 chr3:196842797-196846401*DLG1*2.0850.1083.8330.01558 chr12:122825299-122826244*CLIP1*2.0580.0733.0710.07364 chr1:173961892-173962273*RC3H1*2.0540.1333.4180.09039 chrY:2829114-2829687*ZFY*2.0180.0383.0100.02132 chr11:85707868-85714494*PICALM*1.9560.0163.1540.04884 chr2:9083315-9098771*MBOAT2*1.9290.0413.1700.07362 chr3:196807921-196846401*DLG1*1.7350.0323.4630.048119 chr12:69214104-69218431*MDM2*1.7230.3083.4490.12322 chr7:22306582-22357656*RAPGEF5*1.7140.1993.0490.03024 chr3:196831773-196846401*DLG1*1.6960.0073.4490.016346 chr7:90376995-90419967*CDK14*1.6650.3004.9140.07028 chr10:126631025-126631876*ZRANB1*1.6640.0993.1890.01457 chr17:45695715-45696530*NPEPPS*1.6140.0694.4570.000129 chr19:13919649-13920034*ZSWIM4*1.5960.2508.1190.04031 chr21:37619814-37620866*DOPEY2*1.5270.4943.1070.19536 chr2:9083315-9114564*MBOAT2*1.4760.5403.0930.33921 chr5:72354259-72373320*FCHO2*1.4620.3078.2660.03147 chr10:105767934-105778666*SLK*1.3450.2673.2090.02794 chr11:65198239-65205128*NEAT1*1.3110.4213.3660.02930 chr5:72285253-72286691*FCHO2*1.2910.2877.5940.03628 chr5:96058342-96066564*CAST*1.2770.3435.9660.04864 chr1:207200838-207201024*C1orf116*1.2230.2663.9190.031168 chr2:11905658-11907984*LPIN1*1.1210.6893.4120.07631 chr8:71071739-71075089*NCOA2*1.1070.7883.5970.01937 chr8:37734626-37735069*RAB11FIP1*0.5070.19311.7250.011172 chr7:20193815-20201493*LOC101927668*0.4980.1063.4780.02329 chr8:37727937-37735069*RAB11FIP1*0.1780.0016.3830.075111Upregulated circRNAs (Fold change in RPM\>3, host gene below detection limit)  chr12:9020437-9021799*A2ML1*  50.753780.009406105 chr1:12638745-12639440*DHRS3*  26.730410.00249156 chr3:141231004-141259451*RASA2*  19.349440.00232940 chr14:31596990-31638674*HECTD1*  17.701150.0239453 chr2:192557928-192558280*LOC105747689*  15.433530.04438129 chr6:168271062-168303066*MLLT4*  11.835060.05694933 chr17:57430575-57430887*YPEL2*  10.510280.012152 chr12:27521194-27529349*ARNTL2*  10.026070.01847230 chr2:29344239-29404563*CLIP4*  8.8688690.01216632 chr2:202010100-202014558*CFLAR*  6.5532190.04138837 chr21:16386664-16415895*NRIP1*  6.2765860.0298764 chr16:21973780-21987564*UQCRC2*  5.7705870.05643942 chr7:20198596-20198714*LOC101927668*  5.5382430.1962454 chr16:48581917-48596355*N4BP1*  4.4417510.03302127 chr3:152882554-152965320   3.1732890.03949521Upregulated circRNAs (No junction spanning reads in the EpSCs)   chr6:47675349-47684712     80 chr9:99797007-99797975*CTSV*    74 chr4:15008928-15034835*CPEB2*    74 chr12:8991708-8995957*A2ML1*    66 chr4:87869649-87968746*AFF1*    60 chr1:6659106-6659512*KLHL21*    55 chr19:9004868-9006766*MUC16*    45 chr11:18722479-18722744*TMEM86A*    42 chr6:168271062-168299147*MLLT4*    37 chr16:25066139-25123317     34 chr4:40596274-40598817*RBM47*    33 chr18:47455881-47463767*MYO5B*    33 chr18:47563219-47566684*MYO5B*    30 Table 2.Downregulated circRNAs during differentiation of EpSCs.Location (HG19)Host geneFold change (CTL)*P*-valueFold change (RPM)*P*-valueΔ junction spanning readsDownregulated circRNAs (Fold change in RPM\<0.33)    chr6:35586872-35610620*FKBP5*2.3290.1740.0990.002−52 chr9:95018961-95048121*IARS*0.4860.0240.2920.012−25 chr2:10559859-10560261*HPCAL1*1.9350.3030.3030.033−21 chr13:42385360-42407667*VWA8*0.4740.1710.3160.059−20Downregulated circRNAs (Fold change in RPM\<0.4, host gene below detection limit) chr12:52913665-52913803*KRT5*  0.1310.002−187 chr6:56482926-56483031   0.2780.002−34 chr3:114069120-114070725*ZBTB20*  0.3250.036−25 chr7:6505750-6505876*KDELR2*  0.3460.015−21 chr14:80963811-80997230*CEP128*  0.3480.254−20 chr14:105413222-105413717   0.3490.101−29 chr11:62299899-62299998*AHNAK*  0.3600.179−27

There was a significant correlation between fold change in RPM and fold change in CTL ratio indicating that many circRNAs are up-/downregulated independent of host gene expression ([Fig. 2C](#f0002){ref-type="fig"}). However, it was also observed that some circRNAs with an increased CTL ratio were not upregulated per se. Instead, the increased CTL ratio was due to their respective host genes being downregulated (e.g. *MFSD2A, CTEN, LDLRAD3*, and *ADAMTSL5*). Likewise, some circRNAs were upregulated along with their linear host genes (e.g. *RAB11FIP1, CAST* and *FCHO2*) ([Fig. 2C](#f0002){ref-type="fig"}).

Upregulated circRNAs may function as miRNA sponges {#s0002-0003}
--------------------------------------------------

Next, we compared the number of AGO2 binding sites between circRNAs upregulated independent of their linear host genes (RPM- and CTL fold change \>3) and stably expressed circRNAs (RPM- and CTL fold change \<1.5 and \>0.67) using the web tool CircInteractome \[[@cit0041]\]. This tool integrates 93 independently reported CLIP datasets from various RNA binding proteins (RBPs), including AGO2. We found that upregulated circRNAs (indicated by green in [Fig. 2C](#f0002){ref-type="fig"}) had significantly more AGO2 binding sites than stably expressed circRNAs (indicated by red in [Fig. 2C](#f0002){ref-type="fig"}) ([Fig. 3A](#f0003){ref-type="fig"}). Among the upregulated circRNAs the following seven had more than 10 AGO2 binding sites: hsa_circ_0109315 (*ZNF91*), hsa_circ_0031482 (*HECDT1*), hsa_circ_0078617 (*MAP3K4*), hsa_circ_0020028 (*SHOC2*), hsa_circ_0008812 (*RAD23B*), hsa_circ_0001543 (*NR3C1*) and hsa_circ_0126525 (*SLAIN2*). Among the many more stably expressed circRNAs only the following 12 had more than 10 AGO2 binding sites: hsa_circ_0000039 (*YTHDF2*), hsa_circ_0072732 (*ERBIN*) hsa_circ_0001461 (*FAT1*), hsa_circ_0001021 (*AFTPH*), hsa_circ_0061394 (*BACH1*), hsa_circ_0001551 (*RARS*), hsa_circ_0027491 (*MDM2*), hsa_circ_0001550 (*RARS*), hsa_circ_0001741 (*TNPO3*), hsa_circ_0001247 (*ATXN10*) and hsa_circ_0000620 (*AAGAB*). Therefore, the ratio of circRNAs with more than 10 AGO2 binding sites was significantly higher for the upregulated circRNAs (*P* = 0.0002). Figure 3.Upregulated circRNAs may function as miRNA sponges. (A) Column scatter plot comparing the number of AGO2 binding sites in the upregulated- and stably expressed circRNAs, respectively. The mean number of AGO2 binding sites was 19.2 for the upregulated circRNAs and 3.44 for the stably expressed circRNAs. (B) Scatter plot comparing the number of AGO2 binding sites with the number of predicted miRNA binding sites in the upregulated circRNAs (green dots) and stably expressed circRNAs (red dots). A positive correlation between AGO2 binding and predicted miRNA binding sites was observed. Host genes of the best miRNA sponge candidates are indicated. (C) Column scatter plot comparing the number of miRNA binding sites in the upregulated- and stably expressed circRNAs, respectively. The mean number of miRNA binding sites was 42.5 for the upregulated circRNAs and 26.8 for the stably expressed circRNAs. circRNAs with more than 10 AGO2 binding sites are indicated in orange.

We also compared the number of predicted miRNA binding sites between upregulated- and stably expressed circRNAs using CircInteractome \[[@cit0041]\], which use the TargetScan 7.0 algorithm for this purpose. There was a significant correlation between AGO2 binding and predicted miRNA binding sites ([Fig. 3B](#f0003){ref-type="fig"}). The fraction of circRNAs with more than 10 AGO2 binding sites and a high number of predicted miRNA binding sites (\>30, indicated by orange in [Fig. 3C](#f0003){ref-type="fig"}) was significantly larger for the upregulated circRNAs (*P*\<0.0001). Among all, the upregulated circRNAs from the *HECTD1* and *ZNF91* genes were the best candidates for being miRNA sponges when considering both AGO2 binding and predicted miRNA binding sites ([Fig. 3B](#f0003){ref-type="fig"}). Most notably, circZNF91 (hsa_circ_0109315) contain 24 miR23b-3p binding sites, of which most have strong binding also outside of the seed sequence. Most of these sites overlap with the seed sequence of miR766-3p for which 23 binding sites are present (Figure S4). miR23b-3p is an important regulator of keratinocyte differentiation making it likely that circZNF91 exerts its function in differentiation by sponging this miR \[[@cit0042]\]. The binding sites for miR23b-3p were not predicted by CircInteractome, but have previously also been found by Guo and colleagues \[[@cit0006]\].

Global perturbation of host gene expression by knockdown of DNMT3A and DNMT3B {#s0002-0004}
-----------------------------------------------------------------------------

DNMT3A epigenetically promotes the expression of most genes with active enhancers in human EpSCs, through hydroxymethylation of the center of these enhancers, in a TET2 dependent manner \[[@cit0026]\]. Furthermore, DNMT3A inhibits other genes through methylation of their promoters \[[@cit0043]\]. Therefore, to compare our results ([Fig. 2C](#f0002){ref-type="fig"}) with a setting where most changes in circRNA expression would be expected to be indirect, we analyzed RNA-seq data from human EpSCs treated with short-hairpin RNAs (shRNAs) against *DNMT3A* in triplicate using the same strategy for circRNA detection as described above. It was observed that upon *DNMT3A* knockdown many circRNAs were significantly upregulated ([Fig. 4A](#f0004){ref-type="fig"} and [B](#f0004){ref-type="fig"}), and the mean RPM as well as the mean CTL ratios were significantly higher for the knockdown cells compared to control cells (*P*\<0.0001 for both RPM and for CTL, respectively). The correlation between fold change in RPM and fold change in CTL ratios (Pearson\'s correlation coefficient, r^2^ = 0.057) was much weaker than what was observed upon differentiation of the EpSCs, indicating that these changes were largely depended on changes in host gene expression ([Fig. 4C](#f0004){ref-type="fig"}). Figure 4.Knockdown of *DNMT3A*, but not *DNMT3B*, induce circRNA expression in a host gene dependent manner. (A) Many circRNAs are upregulated upon *DNMT3A* knockdown. (B) Many circRNAs are upregulated relative to their respective host genes upon *DNMT3A* knockdown. (C) The changes in circRNA expression are largely related to changes in host gene expression (only few circRNAs are on the diagonal). (D) Only a few circRNAs are up/downregulated upon *DNMT3B* knockdown. (E) Only a few circRNAs are up/downregulated relative to their respective host genes upon *DNMT3B* knockdown. (F) The changes in circRNA expression are largely independent of changes in host gene expression (most circRNAs are on the diagonal).

DNMT3A and DNMT3B regulate gene expression through non-overlapping functions in EpSCs \[[@cit0026]\], and DNMT3B has a known role in gene body methylation \[[@cit0026]\],\[[@cit0044]\],\[[@cit0045]\]. Thus, it was not surprising that *DNMT3B* knockdown had opposite effects, relative to *DNMT3A* knockdown, on circRNA expression. Here, only few circRNAs were changed by more than three fold ([Fig. 4D](#f0004){ref-type="fig"} and [4E](#f0004){ref-type="fig"}), and the mean RPM was not significantly changed (*P* = 0.05), while the mean CTL ratio was slightly higher for the control cells compared to the knockdown cells (*P*\<0.001). Moreover, a very strong correlation was observed between fold change in RPM and fold change in CTL ratios (Pearson\'s correlation coefficient, r^2^ = 0.562) indicating that the small changes observed were largely independent of changes in host gene expression ([Fig. 4F](#f0004){ref-type="fig"}).

Upregulated circRNAs are unlikely to be regulated by DNA methylation {#s0002-0005}
--------------------------------------------------------------------

The overlap between circRNAs upregulated independent of their linear host genes upon differentiation (upper right corner in [Fig. 2C](#f0002){ref-type="fig"}), circRNAs upregulated independent of their linear host genes upon *DNMT3A* knockdown (upper right corner in [Fig. 4C](#f0004){ref-type="fig"}) and circRNAs upregulated independent of their linear host genes upon *DNMT3B* knockdown (upper right corner in [Fig. 4F](#f0004){ref-type="fig"}) was very limited ([Fig. 5](#f0005){ref-type="fig"}). None of the 19 circRNAs upregulated independent of their linear host genes upon differentiation were also upregulated independent of their linear host genes upon *DNMT3A*- or *DNMT3B* knockdown, and only one circRNA, derived from the *ALS2* gene (hsa_circ_0001093), was common between *DNMT3A*- and *DNMT3B* knockdown ([Fig. 5](#f0005){ref-type="fig"}). Figure 5.Upregulated circRNAs upon differentiation is unlikely to be regulated by DNA methylation. Venn diagram illustrating the overlap of circRNAs upregulated independent of their linear host genes upon differentiation, -upon *DNMT3A* knockdown and -- upon *DNMT3B* knockdown.

Upregulated circRNAs have less Alu-mediated biogenesis {#s0002-0006}
------------------------------------------------------

We searched for inverted homologous *Alu* repeats within a 20 kbp window around the back-splicing junction of the circRNAs. The fraction of circRNAs without inverted homologous *Alu* repeats within this window was 0.42 (8/19) and 0.18 (35/192) for upregulated circRNAs and stably expressed circRNAs, respectively. This difference was statistically significant (*P* = 0.01). The fraction of circRNAs without inverted homologous *Alu* repeats within a 10 kbp window was 0.53 and 0.27 for upregulated circRNAs and stably expressed circRNAs, respectively. This difference was also statistically significant (*P* = 0.02). Together these analyses indicate that the upregulated circRNAs are less prone to undergo *Alu*-mediated biogenesis.

Upregulated circRNAs are deregulated in cutaneous squamous cell carcinoma {#s0002-0007}
-------------------------------------------------------------------------

The malignant counterpart of keratinocytes has previously been explored for circRNA expression using a microarray approach \[[@cit0046]\]. Among the nineteen circRNAs upregulated independent of their linear host genes upon differentiation circMAP3K4 (hsa_circ_0078617) and circDLG1 (hsa_circ_0008583) were also shown to be upregulated in cutaneous squamous cell carcinoma, while circACVR2A (hsa_circ_0001073) were shown to be downregulated \[[@cit0046]\].

Discussion {#s0003}
==========

In this study, we found that circRNAs are abundantly expressed and upregulated during EpSC differentiation. This was not surprising, as it has previously been shown that circRNAs are upregulated during neuronal differentiation \[[@cit0002]\] and that non-proliferating cells have higher levels of circRNA expression compared to proliferating cells \[[@cit0047]\]. These observations are likely to be explained, in part, by circRNAs being passively diluted during cell proliferation and accumulating in terminally differentiated cells due to their high stability. However, our results also point towards a coordinated regulation of a subset of circRNAs during differentiation of EpSCs.

First, many of the up- and downregulated circRNAs were changed independently of their respective host genes and a positive correlation between fold change in RPM and fold change in CTL ratios was observed upon differentiation (Pearson\'s correlation coefficient, r^2^ = 0.165). On the other hand, artificial manipulation of host gene expression by inhibition of *DNMT3A*, which epigenetically regulate most human genes through methylation of promotor and enhancer regions, did not confer a strong correlation between fold change in RPM and fold change in CTL ratios (Pearson\'s correlation coefficient, r^2^ = 0.057). In particular, a large number of circRNAs had increased CTL ratios without an increase in RPM. The expression of these host genes is decreased while the circRNAs remain at similar levels, possibly due to their higher stability relative to mRNA \[[@cit0048]\]. These genes are likely downregulated due to loss of enhancer hydroxymethylation, as DNMT3A cooperate with TET2 to maintain high levels of hydroxymethylation at the center of enhancers of actively transcribed genes \[[@cit0026]\]. Likewise, some of the host genes, which were strongly upregulated, produced strongly upregulated circRNAs. These genes are likely upregulated due to loss of promoter methylation. In line with this, it has previously been shown that circRNA-producing genes have significantly higher levels of H3K27Ac and lower levels of DNA methylation in their promoter regions relative to genes that do not \[[@cit0048]\], indicating that actively transcribed genes produce more circRNA. Interestingly, the opposite effects on circRNA expression were observed upon *DNMT3B* knockdown. Here, only few circRNAs were significantly changed and a very strong correlation was observed between fold change in RPM and fold change in CTL ratios (Pearson\'s correlation coefficient, r^2^ = 0.562). It has previously been shown that DNMT3A and DNMT3B regulate gene expression through non-overlapping mechanisms in EpSCs \[[@cit0026]\], and DNMT3B is more susceptible to bind and methylate gene bodies \[[@cit0026]\],\[[@cit0044]\],\[[@cit0045]\]. Therefore, our results points towards that gene body methylation may play a role in regulating the expression of some circRNAs. However, there was no overlap between circRNAs upregulated independently of their respective host genes upon *DNMT3A* or *DNMT3B* knockdown and upon differentiation. Therefore, these results indicate that circRNAs are generally not directly regulated by DNA methylation during EpSC differentiation.

Second, circRNAs upregulated independently of their host genes are significantly more prone to bind AGO2 compared to stably expressed circRNAs. circRNAs prone to AGO2 binding also contained high numbers of predicted miRNA binding sites. If the observed upregulation of circRNAs in the differentiated cells is entirely passive this would not have been expected. Instead, our results are in line with the previously proposed hypothesis that differentiated cells should not react to weak autocrine and paracrine cellular signals with strong regulatory activities, and that this may be achieved by differentiated cells being less prone to miRNA regulation due to higher levels of circRNAs with miRNA sponging function compared to proliferating cells \[[@cit0047]\]. In particular, the upregulated circRNAs derived from *ZNF91* and *HECTD1* are strong candidates for being miRNA sponges, and circZNF91 has previously been suggested to function as a miRNA sponge in human cells \[[@cit0006]\]. circZNF91 contains most of the host gene\'s 3' UTR and has 24 and 23 individual binding sites for miR-23b-3p and miR-766-3p, respectively. miR-23b-3p has been directly implicated in differentiation of EpSCs to keratinocytes \[[@cit0042]\], whereas miR-766 targets *DNMT3B* \[[@cit0049]\] and is upregulated in cutaneous squamous cell carcinoma \[[@cit0050]\].

Third, the upregulated circRNAs have less *Alu*-mediated biogenesis coinciding with *DHX9* being upregulated in the differentiated cells \[[@cit0026]\]. Since DHX9 specifically suppress the expression of circRNAs with flanking reverse complementary *Alu* repeats \[[@cit0015]\], we propose that the cells actively suppress the expression of circRNAs with no or unwanted functions, which would otherwise accumulate in non-proliferating cells, through upregulation of *DHX9*.

Finally, many of the independently upregulated circRNAs are derived from epidermal developmental genes and genes involved in stemness and epidermal growth factor signaling. These circRNAs may have other functions unrelated to their host genes, but it has been shown for several circRNAs that they can regulate the expression of their own host genes \[[@cit0008]\],\[[@cit0022]\],\[[@cit0051]\]. However, it remains to be elucidated if this is a general mechanism among circRNAs.

Future studies should aim at uncovering the specific roles and functions of circRNAs, like circZNF91 and circHECDT1, in EpSC homeostasis and differentiation and to further explore the mechanisms responsible for their regulation.

In conclusion, we have shown that circRNAs are abundantly expressed in EpSCs and upregulated during differentiation to keratinocytes in a coordinated manner. Independently upregulated circRNAs are generally less prone to *Alu*-mediated biogenesis and unlikely to be directly regulated by DNA methylation during differentiation. Finally, several upregulated circRNAs, including two derived from the *HECTD1* gene and one from *ZNF91*, are likely to have miRNA sponging functions.

Materials and methods {#s0004}
=====================

Ethics {#s0004-0001}
------

No primary human samples or animal models were used in this study and experimental procedures were previously evaluated and approved by CEEA (Ethical Committee for Animal Experimentation) of the Government of Catalonia \[[@cit0026]\].

circRNA detection in RNA sequencing data {#s0004-0002}
----------------------------------------

We analyzed RNA-seq data generated in triplicates from EpSCs and differentiated keratinocytes, as well as *DNMT3A* and *DNMT3B* knockdowns in EpSCs, for circRNA expression. This was done using a more stringent version of the Find_circ pipeline, which we have previously described \[[@cit0007]\], and the CircExplorer pipeline \[[@cit0011]\]. Libraries were prepared with the TruSeq®Stranded Total Sample Preparation kit (Illumina Inc.) according to the manufacturer\'s protocol. Ribosomal RNA was depleted from 0.5 µg of total RNA using the Ribo-Zero Gold Kit (Illumina Inc.). The RNA-seq data has previously been published \[[@cit0026]\], but not previously analyzed for circRNA expression.

All circRNA data analyses were based on the Find_circ pipeline. However, all circRNA candidates not detected by CIRCexplorer were manually inspected to exclude obvious artifacts due to sequence homology. Reads per million (RPM) refers to sequencing reads aligning across the particular back-splicing junction and circular-to-linear (CTL) ratios were defined as the average number of linear reads spanning the splice donor- and splice acceptor sites of the back-splicing junction divided by the number of reads spanning the back-splice junction. circRNAs with less than 15 linear splice donor and splice acceptor reads in the replicates of the EpSCs and differentiated keratinocytes, respectively, were excluded from the CTL analyses. In addition, circRNAs with no splice donor and -acceptor reads in two out of three replicates, of either the EpSCs or the differentiated keratinocytes, were excluded from CTL analyses. The same bioinformatics pipelines and criteria were used when analyzing the *DNMT3A* and *DNMT3B* knockdown RNA-seq data.

Accession numbers {#s0004-0003}
-----------------

The genomic data used in this paper have previously been deposited in the NCBI Gene Expression Omnibus (GEO) database with accession number: GSE65838.

Analyses of AGO2 binding sites and predicted miRNA target sites {#s0004-0004}
---------------------------------------------------------------

We used CircInteractome \[[@cit0041]\] for the AGO2 binding and miRNA binding site prediction analyses of stably expressed- and upregulated circRNAs upon differentiation of EpSCs. For these analyses circRNAs for which internal splicing cannot be predicted (i.e. most of the circRNA is intronic due to usage of a cryptic splice site) were not included in the analyses. For instance, the upregulated circRNA from the *MED13L* gene (hsa_circ_0000442) was predicted to have 277 miRNA binding sites. However, as it is largely intronic (Figure S5), and could be subject to internal splicing, it was removed from the analyses.

Analyses of flanking Alu repeats {#s0004-0005}
--------------------------------

The *Alu* repeats were obtained from the UCSC Browser RepeatMasker track \[[@cit0052]\] and analyzed as described \[[@cit0053]\]. In brief, flanking regions (20 kb or 10kb) around circRNAs were intersected with *Alu* repeats. Inverted homologous *Alu* repeats in separate flanks of circRNAs were annotated along with their closest distance. *Alu* repeats within the same subfamily, e.g. AluJ or AluS, were considered homologous.

Sanger sequencing across back-splicing junctions of circRNA candidates {#s0004-0006}
----------------------------------------------------------------------

cDNA synthesis was performed on 500 ng total RNA from EpSCs using the M-MLV reverse-transcriptase (Thermo Fisher Scientific, Waltham, Massachusetts, USA) according to the manufacturer\'s instructions using random primers. The cDNA was diluted fivefold in PCR grade water and used as template for PCR. The reaction mixtures consisted of 2--5 µL template in a total volume of 20 µL using a 1x final concentration of the LC480 HRM Scanning Master (Roche Diagnostics, Mannheim, Germany), and a final MgCl~2~ concentration of 2 mM. Primers (Table S1) were used at a final concentration of 300 nM. The cycling protocol was initiated by one cycle at 95°C for 10 minutes, followed by 40 PCR cycles at 95°C for 10 seconds, 60°C for 20 seconds, and 72°C for 20 seconds. Five µL of each PCR product was loaded on 2% agarose gels stained with SYBR™ Safe DNA Gel Stain (Thermo Fisher Scientific) and visualized under UV light after electrophoresis. The remaining 15 µL of each PCR product was cleaned up using the QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) and Sanger sequenced in both forward and reverse directions using the service of GATC (GATC Biotech, Konstanz, Germany).

Statistical analyses {#s0004-0007}
--------------------

The reproducibility between RNA-seq replicates was compared using linear regression and comparisons of circRNA expression (RPM and CTL ratios) between groups was done using the Wilcoxon signed-rank tests. For generation of volcano plots, t-tests were employed to calculate *P*-values. The *P*-values were not used for dividing circRNAs into groups of stably expressed and upregulated circRNAs. This was based solely on fold changes in expression. Comparison of AGO2 binding and predicted miRNA binding sites between groups were done using Mann-Whitney tests as the data were not normally distributed according to the D\'Agostino & Pearson normality test. Analyses of 2 × 2 tables were done using Chi-square tests. All statistical tests were performed using Prism 7 (GraphPad, La Jolla, CA, USA).
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